Month: August 2026

Release – GeoVax Chairman and CEO David Dodd to Participate in 2026 Georgia Life Sciences Summit

Posted on by [email protected]
GeoVax

Research News and Market Data on GOVX

Former Georgia Life Sciences Chair Selected for CEO Spotlight and Private Global Health Policy Roundtable With U.S. Rep. Rich McCormick

ATLANTA, Ga., August 20, 2026 — GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies for infectious diseases and cancer, today announced that Chairman, President and Chief Executive Officer David Dodd will participate in two leadership and policy events associated with the 2026 Georgia Life Sciences Summit, August 25–26, at the Performing Arts Center in Sandy Springs, Georgia.

Dodd, a former Chair of Georgia Life Sciences, has been selected as one of four biotechnology CEOs participating in “CEO Spotlights: Decisions That Define a Company,” presented by BioSpark Labs, on August 26. The CEO Spotlights feature 10-minute, TED-style presentations focused on pivotal decisions, challenges and inflection points that have shaped the trajectory of each participating company.

Dodd will draw upon GeoVax’s evolution to discuss the leadership and strategic decisions involved in building and advancing a biotechnology company through changing scientific, financial, regulatory and public-health environments. The presentation will offer a candid perspective on navigating uncertainty, allocating resources, advancing innovative technologies and maintaining a long-term strategic vision while confronting the realities inherent in building a clinical-stage biotechnology company.

GeoVax today is advancing a diversified portfolio built around its Modified Vaccinia Ankara (MVA) vaccine platform and novel oncology technologies. Its programs include GEO-MVA, the Company’s vaccine candidate for mpox and smallpox; MVA-based vaccine candidates targeting Ebola, Sudan Ebola and Marburg viruses; and Gedeptin®, a novel gene-directed therapy for solid tumors.

“Building a biotechnology company is rarely a straight line,” said Dodd. “It requires making consequential decisions with incomplete information, adapting to changing circumstances and remaining focused on the scientific and strategic opportunities that can ultimately create meaningful value. I look forward to sharing some of the decisions and lessons that have shaped GeoVax’s journey with Georgia’s life sciences community.”

Dodd will be joined in the CEO Spotlight program by Samir Patel, President and CEO of Moonlight Therapeutics; Dr. Nikhil L. Shah, CEO and Co-Founder of Nephrodite; and Gareth Sheridan, Founder and CEO of Nutriband.

Private Roundtable with Congressman Rich McCormick

On August 25, Dodd will also participate in a private roundtable discussion with U.S. Representative Rich McCormick (GA-07), convened by Georgia Life Sciences, the Global Health Technologies Coalition and The Kyle House Group.

The roundtable will bring together leaders from Georgia’s global health, biotechnology, nonprofit and private sectors to discuss the state’s leadership in advancing global health and development through innovation, research and public-private partnerships. Participants will also have the opportunity to discuss key policy priorities and issues before Congress directly with Congressman McCormick.

For GeoVax, the discussion provides an opportunity to contribute perspectives informed by the Company’s work in infectious disease vaccines, medical countermeasures and global health preparedness, as well as the challenges faced by emerging biotechnology companies working to translate scientific innovation into products addressing significant public-health needs.

“Georgia has developed an increasingly important life sciences and global health ecosystem that brings together scientific innovation, entrepreneurship, academic expertise, public policy and investment,” Dodd said. “Having previously served as Chair of Georgia Life Sciences, I am especially pleased to participate in this year’s Summit and to engage with Congressman McCormick and other leaders on how we can further strengthen Georgia’s – and America’s – capacity for biotechnology innovation, health security and global health leadership.”

The Georgia Life Sciences Summit is the organization’s flagship annual gathering, bringing together leaders from industry, academia, government and the investment community to address major issues affecting scientific research, product development, financing, business development and public policy while showcasing innovation across Georgia’s life sciences sector.

About GeoVax

GeoVax Labs, Inc. is a clinical-stage biotechnology company focused on the development of vaccines and immunotherapies addressing high-consequence infectious diseases and solid tumor cancers. GeoVax’s priority program is GEO-MVA, a Modified Vaccinia Ankara (MVA)–based vaccine targeting mpox and smallpox. The program is advancing under an expedited regulatory pathway, with plans to initiate a pivotal Phase 3 clinical trial in the second half of 2026, to address critical global needs for expanded orthopoxvirus vaccine supply and biodefense preparedness. In oncology, GeoVax is developing Gedeptin®, a gene-directed enzyme prodrug therapy (GDEPT) designed to enhance immune checkpoint inhibitor activity. Gedeptin has completed a multicenter Phase 1/2 clinical trial in advanced head and neck cancer and is being advanced into combination strategies, including planned neoadjuvant and first-line settings. GeoVax maintains a global intellectual property portfolio supporting its infectious disease and oncology programs and continues to evaluate strategic partnerships and funding opportunities aligned with its development priorities. For more information, visit www.geovax.com.

Forward-Looking Statements

This release contains forward-looking statements regarding GeoVax’s business plans. The words “believe,” “look forward to,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax is able to obtain acceptable results from ongoing or future clinical trials of its investigational products, GeoVax’s immuno-oncology products and preventative vaccines can provoke the desired responses, and those products or vaccines can be used effectively, GeoVax’s viral vector technology adequately amplifies immune responses to cancer antigens, GeoVax can develop and manufacture its immuno-oncology products and preventative vaccines with the desired characteristics in a timely manner, GeoVax’s immuno-oncology products and preventative vaccines will be safe for human use, GeoVax’s vaccines will effectively prevent targeted infections in humans, GeoVax’s immuno-oncology products and preventative vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete development, there is development of competitive products that may be more effective or easier to use than GeoVax’s products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control.

Further information on our risk factors is contained in our periodic reports on Form 10-Q and Form 10-K that we have filed and will file with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

Company Contact:

[email protected]

678-384-7220

Media Contact:

Jessica Starman

[email protected] 

Release – Snail Games Unveils Gamescom 2026 Lineup Headlined by Upcoming AAA Title

Posted on by [email protected]
Snail, Inc logo

Research News and Market Data on SNAL

August 20, 2026 at 2:05 PM EDT

PDF Version

CULVER CITY, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) — Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading independent global developer and publisher of interactive digital entertainment, unveils its Gamescom 2026 lineup that includes developing AAA titles, upcoming releases, and content updates across existing titles.

Taking the spotlight at Gamescom 2026 is the 9 Yin Sutra universe. Following the recent ChinaJoy announcement of 9 Yin Sutra: Immortal, Snail Games CEO, Hai Shi, will officially unveil another internally developed AAA title, expanding the franchise into a parallel timeline and alternate universe. Both titles are rooted in the acclaimed Age of Wushu IP, offering distinct takes on the martial arts world while building on one of Snail Games’ most established franchises. Alongside the upcoming 9 Yin Sutra titles, Snail Games will also showcase For The Stars, the Company’s other developing AAA title and ambitious space survival experience.

Meanwhile, Honeycomb: The World Beyond is gearing up for its recently announced September 8, 2026 launch. The upcoming survival adventure will be featured at Gamescom, giving attendees an early look at the game ahead of release. Players can also get an early, hands-on experience through a PC-exclusive preview demo expected to launch on August 31, 2026.

Bellwright will celebrate its community of over 1 million players while teasing an upcoming update with one of its most anticipated developments. Consistently the #1 player-requested feature, Bellwright’s latest feature represents a major step in how players will experience and move through the world. The Gamescom showcase will offer an early look at what’s coming while celebrating the community that has helped shape Bellwright.

Leading into Gamescom, Echoes of Elysium has received a new weather-focused tempest that makes rain a more meaningful part of gameplay. Rain now directly affects ships and their contents, with wet components and stored items gaining weight and drag. Certain stations can become inoperable when soaked, while the updated weather system brings a darker, more atmospheric feel to the world.

Visit the Snail Games Booth at Gamescom Hall 8.1 A-041

For Media interested in interviews at Gamescom please reach out to [email protected]

For Creators interested in collaborations please reach out to [email protected]

About Snail, Inc.
Snail, Inc. (Nasdaq: SNAL) is a leading global independent developer and publisher of interactive digital entertainment for consumers around the world, with a premier portfolio of premium games designed for use on a variety of platforms, including consoles, PCs, and mobile devices. For more information, please visit: https://snail.com/.

Forward-Looking Statements
This press release contains statements that constitute forward-looking statements. Many of the forward-looking statements contained in this press release can be identified by the use of forward-looking words such as “anticipate,” “believe,” “could,” “expect,” “should,” “plan,” “intend,” “may,” “predict,” “continue,” “estimate” and “potential,” or the negative of these terms or other similar expressions. Forward-looking statements appear in a number of places in this press release and include, but are not limited to, statements regarding Honeycomb: The World Beyond gearing up for its recently announced September 8, 2026 launch; the survival adventure being featured at Gamescom, players getting an early hands-on experience through a PC-exclusive preview demo launching August 31; Bellwright teasing one of its most anticipated developments: traversal at Gamescom: Snail Games USA showcasing For The Stars and the 9 Yin Sutra universe; and Snail Games USA’s CEO officially unveiling another new 9 Yin Sutra title at Gamescom, 9 Yin Sutra, expanding the franchise into a parallel timeline and alternate universe. Any forward-looking statements included herein reflect our current views, and they involve certain risks and uncertainties, including, among others, the ability to launch The World Beyond on September 8, 2026 , the PC-exclusive demo and the other new games and titles when anticipated; acceptance of the Company’s titles in the marketplace and the successful development, marketing or sale of our titles and our ability to retain our key employees or maintain our Nasdaq listing. These risks should not be construed as exhaustive and should be read together with the other cautionary statement included in our Annual Report on Form 10-K for the year ended December 31, 2025, subsequent Quarterly Reports on Form 10-Q and current reports on Form 8-K filed with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it was initially made. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, changed circumstances or otherwise, unless required by law.

Investor Contact:
John Yi and Steven Shinmachi
Gateway Group, Inc.
949-574-3860
[email protected]

Bitcoin Breaks Back Above $70,000 as Yields Tumble and Washington Turns Friendlier

Posted on by [email protected]

Bitcoin surged back above $70,000 this week for the first time in more than two months, climbing past $71,500 after a rapid string of catalysts hit the crypto market at once. The move builds on a 7% rally the day before that erased $2.7 billion in short positions, and it comes alongside gains across other digital assets, including a 23% jump in a token tied to the offshore derivatives exchange Hyperliquid.

The rally traces back to two connected developments. US Treasury Secretary Scott Bessent moved to push bond yields lower through debt buybacks targeting longer-dated Treasuries, a step that signals concern over the recent rise in yields. That move sent yields down and pushed the dollar to a three month low. Weaker yields and a softer dollar tend to push investors toward risk assets, and bitcoin was a clear beneficiary. Jeff Mei, chief operating officer at crypto exchange BTSE, tied the move directly to that dynamic, noting that falling yields and a weaker dollar typically send risk assets higher.

The second catalyst came out of Washington. President Trump met with crypto industry executives from firms including Coinbase, Payward, and Blockchain.com, a meeting that appears to have revived optimism around the Clarity Act, the crypto market structure bill that stalled before it could reach a Senate vote ahead of the chamber’s August recess. Trump also indicated the administration is exploring ways to let Hyperliquid operate domestically, a signal that helped drive the token’s sharp gain.

Taken together, the moves point to a market reacting to policy signals as much as price momentum. Lower yields make holding non yielding assets like bitcoin more attractive relative to bonds, while renewed talk of a functioning regulatory framework removes some of the uncertainty that has weighed on institutional participation in digital assets. Neither of those forces guarantees the rally holds. Bond buybacks and political meetings can shift sentiment quickly, but they do not resolve the underlying questions around how crypto will ultimately be regulated in the US, and yields could just as easily reverse if inflation data or fiscal concerns resurface.

Bitcoin’s move also comes against a backdrop of a broader risk on tone in markets this week, with gold, oil, and equity futures also higher heading into the open. Whether bitcoin’s push above $70,000 marks a durable shift or another sharp swing in a historically volatile asset will likely depend on whether the Clarity Act gains real traction when the Senate returns from recess, and whether the Treasury’s yield intervention proves temporary or lasting.

For now, the rally has reset sentiment in a market that spent much of the summer on the defensive, and traders will be watching both bond markets and Washington closely for the next signal.

Release – Conduent Collaborates with Google Cloud to Expand Enterprise AI Strategy and Deliver GenAI-Powered eDiscovery Solution

Posted on by [email protected]

Research news and Market Data on CNDT

New GenAI capabilities for Legal Compliance & Analytics help legal teams accelerate review, reduce costs and improve defensibility at scale

August 20, 2026

Legal and Compliance Solutions Commercial Sector

Conduent Incorporated (Nasdaq: CNDT), a global technology-driven business solutions and services company, today announced it is expanding its enterprise AI strategy by collaborating with Google Cloud and integrating Google’s Gemini models into Conduent’s Viewpoint™ platform. The collaboration represents another milestone in Conduent’s strategy to embed GenAI across its technology platforms, helping clients modernize complex, essential workflows while improving speed, quality and operational efficiency.

Corporate legal departments are under increasing pressure to review growing volumes of structured and unstructured information while controlling costs, reducing risk and meeting tighter deadlines. By combining Conduent’s decades of legal operations expertise with Google Cloud’s AI technologies, organizations can analyze complex datasets faster, improve decision-making and deliver more defensible outcomes across eDiscovery and data breach response.

“Enterprise AI is not about replacing expertise, it is about amplifying it,” said George Wehbe, President, Commercial Solutions, Conduent. “Legal professionals are being asked to review exponentially more information with the same resources. By combining Conduent’s legal operations expertise with Google Cloud’s AI capabilities, we’re helping clients make faster, better-informed decisions while maintaining the governance, transparency and defensibility these matters demand.”

Driving Faster, Smarter Legal Outcomes
At the core of the collaboration is Enhanced Review, a GenAI-powered capability within Viewpoint, which applies user-defined protocols to identify relevant content, detect legal issues, and surface high-risk documents early in the review process.

Enabled by Google’s Gemini models, Enhanced Review delivers consistent, explainable results with transparent reasoning that helps legal teams understand not just what was identified, but why.

By embedding GenAI, Enhanced Review enables:

  • Faster insights — key case questions answered in minutes, not days
  • Lower costs — 30–60% reduction in document-intensive analysis effort
  • Reduced risk — improved accuracy, auditability, and defensibility

Extending AI Across the Legal Workflow
Beyond document review, Conduent’s collaboration with Google Cloud helps extend GenAI across the broader legal lifecycle. Viewpoint Apps use AI-powered analysis to convert large volumes of unstructured documents into structured, review-ready outputs, including chronologies, privilege logs and case reports, to accelerate insight while reducing manual effort.

In addition, Conduent’s CyberMine®, integrated with Viewpoint Data Breach Analyzer, automates breach response workflows by extracting participant data at scale, often spanning millions of records, deduplicating entries, and generating audit-ready notification lists, significantly reducing both response time and operational burden.

Built for Scale, Security, and Choice
Unlike cloud-only platforms, Viewpoint gives organizations full control over how and where their data is managed. Clients can deploy the full solution as SaaS on Google Cloud, on-premises or through managed services, ensuring alignment with regulatory, security and operational requirements. This flexibility, combined with Google Cloud’s global, high-performance infrastructure, enables organizations to scale eDiscovery operations without compromising data sovereignty or control.

Advancing Innovation in Legal and Compliance
Conduent’s collaboration with Google Cloud reflects a commitment to co-innovation and expanding the role of AI across legal and compliance workflows. Current capabilities focus on eDiscovery and data breach response, with planned expansion into areas such as contract analytics and investigations.

About Conduent
Conduent delivers digital business solutions and services spanning the commercial, government and transportation spectrum – creating valuable outcomes for its clients and the millions of people who count on them. The Company leverages cloud computing, artificial intelligence, machine learning, automation and advanced analytics to deliver mission-critical solutions. Through a dedicated global team of approximately 48,000 associates, process expertise and advanced technologies, Conduent’s solutions and services digitally transform its clients’ operations to enhance customer experiences, improve performance, increase efficiencies and reduce costs. Conduent adds momentum to its clients’ missions in many ways including disbursing approximately $80 billion in government payments annually, enabling approximately 2.0 billion customer service interactions annually, empowering millions of employees through HR services every year and processing over 14 million tolling transactions every day. Learn more at www.conduent.com .

Note: To receive RSS news feeds, visit www.news.conduent.com . For open commentary, industry perspectives and views, visit https://x.com/Conduent , http://www.linkedin.com/company/Conduent or http://www.facebook.com/Conduent .

Trademarks
Conduent is a trademark of Conduent Incorporated in the United States and/or other countries. Other names may be trademarks of their respective owners.

Media Contacts

Remy Kaul

Conduent

[email protected]

Release – Lands’ End Announces Second Quarter Fiscal 2026 Earnings Conference Call

Posted on by [email protected]
Lands' End

Research News and Market Data on LE

DODGEVILLE, Wis., Aug. 20, 2026 (GLOBE NEWSWIRE) — Lands’ End, Inc. (NASDAQ: LE) will host a conference call at 8:30 a.m. Eastern Time on Thursday, September 3, 2026, to discuss its second quarter fiscal 2026 financial results.

A news release will be issued before the call and also be available on the Company’s investor relations website. Listeners may access a live broadcast of the conference call on the Company’s investor relations website: https://investors.landsend.com/ in the Events and Presentations section. An online archive of the broadcast will be available at approximately noon on September 3, 2026.

About Lands’ End, Inc.

Lands’ End, Inc. (NASDAQ: LE) is a leading digital retailer of solution-based apparel, swimwear, outerwear, accessories, footwear, home products and uniforms. Lands’ End offers products online at www.landsend.com, through third-party distribution channels and Company Operated stores. Lands’ End also offers products to businesses and schools, for their employees and students, through the Outfitters distribution channel. Lands’ End is a classic American lifestyle brand that creates solutions for life’s every journey.

CONTACTS:

Lands’ End, Inc.
Bernard McCracken
Chief Financial Officer
(608) 935-4100

Investor Relations:
ICR, Inc.
Tom Filandro
(646) 277-1235
[email protected]

GDEV (GDEV) – Profitability Momentum In Focus Ahead Of Q2 Results

Posted on by [email protected]


Thursday, August 20, 2026

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Jacob Mutchler, Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Q2 results preview. We expect GDEV’s second-quarter results to reflect continued disciplined user acquisition spending and a focus on profitable growth. For context, Q1 revenue increased 2% to $99 million, while adjusted EBITDA increased 15% to $18 million, benefiting from a 13% decline in selling and marketing expense, as illustrated in Figure #1 Q1 Results. The return to top-line growth, following a revenue decline in fiscal 2025, is encouraging.

Facing a difficult revenue comparison. Q2 will lap a relatively strong year-ago quarter, when revenue increased 13% to $120 million, driven in part by elevated performance marketing investment. As such, we believe the more important read-through will be the company’s ability to sustain engagement and monetization while maintaining its more disciplined approach to marketing expenditures.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Trump Paused 50% Tariffs on Canada Hours Before They Hit and the Markets Barely Moved

Posted on by [email protected]

President Trump announced late Tuesday night he is pausing a scheduled 50% tariff on Canadian goods just hours before it was set to take effect at midnight, following eleventh-hour talks between US officials and Canadian Prime Minister Mark Carney’s team. Trump posted that the three-day pause reflects an agreement in principle between the two countries, subject to finalizing formal documents. Notably, US equity futures were essentially unchanged on the news, a muted reaction that tells its own story about how markets are actually reading this development.

Stocks were already under pressure heading into Wednesday, weathering a losing week driven by rising bond yields and oil prices, compounded by a Tuesday tech selloff that spread overnight into Asian markets, where Japan’s Nikkei fell 3% and South Korea’s KOSPI dropped 5%. Against that backdrop, a last-minute tariff pause registering as a non-event for futures markets is itself informative. Trade policy experts have noted the Canadian tariffs, even if implemented, would likely have had limited direct economic impact given the narrower scope of affected goods compared to broader tariff actions earlier in the year. What markets appear to be reading instead is the signal this sends ahead of the larger prize: negotiations over the US-Mexico-Canada Trade Agreement, the actual trade framework governing the bulk of cross-border commerce among the three countries, which remains the more consequential outcome still to be determined.

This tariff pause arrives during an already data-heavy stretch for markets. The Federal Reserve released minutes from its July FOMC meeting the same day, offering additional detail on the internal debate over inflation and the path for interest rates that we detailed in our recent coverage of the divided committee heading into Jackson Hole. Separately, a wave of retail earnings from Target, Lowe’s, and TJX Companies is set to give investors a clearer read on consumer spending trends through the spring and summer, adding yet another variable competing for market attention this week.

For companies operating below the $2 billion market cap threshold, trade policy volatility of this kind carries outsized relevance. Smaller manufacturers, industrial suppliers, and companies with meaningful cross-border supply chains into Canada are directly exposed to tariff uncertainty in a way large multinational companies, with more diversified sourcing and pricing power, often are not. A three-day pause is not resolution, it is a postponement, and the underlying uncertainty over how USMCA negotiations ultimately land remains an open variable for exactly the kind of domestically focused small cap companies that make up a large share of the Russell 2000. Investors in this space should treat this development as one to watch closely rather than a settled outcome, since the finalized documents Trump referenced, and the broader trade framework they sit within, are what will actually determine whether this becomes a durable resolution or simply a delay before the next deadline.

Release – Kratos Receives Multi-Million-Dollar Orders for GAIA 100 Tri-Band Ground Station Systems Through Newly Acquired Orbit

Posted on by [email protected]
Primary Logo

Research News and Market Data on KTOS

August 19, 2026

PDF VersionOrders for both the GAIA 100 5.5-meter and the 6.1-meter systems underscore growing demand for Orbit’s GAIA tri-band S/X/Ka capability with advanced Ka-band tracking systems

SAN DIEGO, Aug. 19, 2026 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc., (NASDAQ: KTOS), a technology company in the defense, national security and global markets, today announced that Orbit Communication Systems Ltd. has received multi-million-dollar orders from multiple international customers for its GAIA 100 Tri-Band 5.5-meter and 6.1-meter antenna systems.

The orders, which support Earth Observation (EO), New Space and satellite communications applications, reflect continued demand for Orbit’s high-performance ground station solutions.

Alongside the announcement, Orbit is revealing the GAIA 100 Tri-Band 6.1, designed to deliver higher gain, improved link margins and enhanced Ka-band tracking performance. Supporting Earth Observation, New Space, defense and satellite communications applications, it combines advanced multi-band capability with a cost-effective, maintenance-free architecture.

“The market is placing increasing emphasis on ground station performance, particularly as satellite operators move toward higher-frequency communications and larger data volumes,” said Daniel Eshchar, General Manager of Orbit Communications Systems. “The GAIA 100 Tri-Band 6.1 was developed to address these evolving requirements by combining enhanced antenna performance, highly accurate Ka-band tracking and a robust, low-maintenance architecture within a single platform.”

The GAIA 100 Tri-Band 6.1 incorporates Orbit’s Auto Track technology, providing the pointing accuracy required for Ka-band communications. By combining integrated RF tracking with Orbit’s control architecture, the system maintains precise satellite alignment throughout the pass, maximizing link performance under demanding operating conditions.

The system’s integrated Radome architecture and robust mechanical design support long-term operation with minimal maintenance. By protecting critical antenna components from environmental exposure, the Radome increases system availability, extends service life and reduces lifecycle costs.

The 6.1-meter GAIA system builds on the proven capabilities of the GAIA family, including uninterrupted horizon-to-horizon tracking, full hemispherical coverage and support for LEO, MEO and GEO missions. Available in multiple antenna sizes and frequency configurations, the GAIA family enables operators to tailor systems to mission requirements while maintaining a common platform architecture.

Acquired by Kratos in March 2026, Orbit significantly expands Kratos’ microwave and digital systems portfolio by adding industry-leading satellite communications (SATCOM), tracking, and communications management technologies for airborne, maritime, land, and space applications. Combined with Kratos’ existing expertise in high-performance RF, microwave, and digital subsystem design and manufacturing, the acquisition strengthens the company’s ability to deliver increasingly integrated, end-to-end communications and mission solutions for defense, national security, and space customers. The combined capabilities position Kratos to address growing global demand for resilient, mission-critical connectivity supporting unmanned systems, satellite communications, electronic warfare, and multi-domain operations while accelerating innovation across rapidly expanding defense and space markets.

About Kratos Defense & Security Solutions
Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) is a technology, products, system and software company addressing the defense, national security, and commercial markets. Kratos makes true internally funded research, development, capital and other investments, to rapidly develop, produce and field solutions that address our customers’ mission critical needs and requirements. At Kratos, affordability is a technology, and we seek to utilize proven, leading-edge approaches and technology, not unproven bleeding edge approaches or technology, with Kratos’ approach designed to reduce cost, schedule and risk, enabling us to be first to market with cost effective solutions. We believe that Kratos is known as an innovative disruptive change agent in the industry, a company that is an expert in designing products and systems up front for successful rapid, large quantity, low-cost future manufacturing which is a value-add competitive differentiator for our large traditional prime system integrator partners and also to our government and commercial customers. Kratos intends to pursue program and contract opportunities as the prime or lead contractor when we believe that our probability of win (PWin) is high and any investment required by Kratos is within our capital resource comfort level. We intend to partner and team with a large, traditional system integrator when our assessment of PWin is greater or required investment is beyond Kratos’ comfort level. Kratos’ primary business areas include virtualized ground systems for satellites and space vehicles including software for command & control (C2) and telemetry, tracking and control (TT&C), jet powered unmanned aerial drone systems, hypersonic vehicles and rocket systems, propulsion systems for drones, missiles, loitering munitions, supersonic systems, space craft and launch systems, C5ISR and microwave electronic products for missile, radar, missile defense, space, satellite, counter UAS, directed energy, communication and other systems, and virtual & augmented reality training systems for the warfighter. For more information, visit www.KratosDefense.com and follow Kratos on LinkedIn and X.

Notice Regarding Forward-Looking Statements
Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Kratos and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Kratos undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Kratos believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Kratos in general, see the risk disclosures in the Annual Report on Form 10-K of Kratos for the year ended December 28, 2025, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the SEC by Kratos.

Press Contact:
Claire Cantrell
[email protected]

Kratos Investor Information:
877-934-4687
[email protected]

Release – 1-800-FLOWERS.COM, Inc. to Release its Fiscal 2026 Fourth Quarter and Year-End Results on Thursday, September 10, 2026

Posted on by [email protected]
1-800-FLOWERS.COM, Inc. – link to home page

Research News and Market Data on FLWS

Aug 19, 2026

JERICHO, N.Y.–(BUSINESS WIRE)– 1-800-FLOWERS.COM, Inc. (NASDAQ: FLWS) (the “Company”),a leading provider of thoughtful expressions designed to help inspire customers to give more, connect more, and build more and better relationships, today announced that the Company will release financial results for its fiscal 2026 fourth quarter and year-end on Thursday, September 10, 2026. The press release will be issued before the market opens and will be followed by a conference call with members of senior management at 8:00 a.m. (ET).

The conference call will be available via live webcast on the Investors section of the Company’s website at www.1800flowersinc.com/investors. A replay of the webcast will be available shortly after the live event has concluded. A telephone replay of the call will be available beginning at 2:00 p.m. (ET) on September 10, 2026, through September 17, 2026, by dialing (855) 669-9658 or (412) 317-0088 for international callers; the passcode is 8022292.

Special Note Regarding Forward-Looking Statements:

Some of the statements contained in the Company’s press release and conference call regarding its fiscal 2026 fourth quarter and year-end results, other than statements of historical fact, may be forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the applicable statements. For a more detailed description of these and other risk factors, please refer to the Company’s SEC filings including its Annual Reports and Forms 10-K and 10-Q available at the Investor Relations section of the Company’s website at 1800flowersinc.com. The Company expressly disclaims any intent or obligation to update any of the forward-looking statements made in the scheduled conference call and any recordings thereof, or in any of its SEC filings, except as may be otherwise stated by the Company.

About 1-800-FLOWERS.COM, Inc.

1-800-FLOWERS.COM, Inc. is a leading provider of thoughtful expressions designed to help inspire customers to share more, connect more, and build more and better relationships. The Company’s e-commerce business platform features an all-star family of brands, including: 1-800-Flowers.com®, 1-800-Baskets.com®, Card Isle®, Cheryl’s Cookies®, Harry & David®, PersonalizationMall.com®, Shari’s Berries®, FruitBouquets.com®, Things Remembered®, Moose Munch®, The Popcorn Factory®, Wolferman’s Bakery®, Vital Choice®, Simply Chocolate® and Scharffen Berger®. Through the Celebrations Passport® loyalty program, which provides members with free standard shipping and no service charge on eligible products across our portfolio of brands, 1-800-FLOWERS.COM, Inc. strives to deepen relationships with customers. The Company also operates BloomNet®, an international floral and gift industry service provider offering a broad range of products and services designed to help members grow their businesses profitably; Napco℠, a resource for floral gifts and seasonal décor; and DesignPac®, a manufacturer of gift baskets and towers. 1-800-FLOWERS.COM, Inc. was recognized among America’s Most Trustworthy Companies by Newsweek for 2024. 1-800-FLOWERS.COM, Inc. was also recognized as one of America’s Most Admired Workplaces for 2025 by Newsweek and was named to the Fortune 1000 list in 2022. Shares in 1-800-FLOWERS.COM, Inc. are traded on the NASDAQ Global Select Market, ticker symbol: FLWS. For more information, visit 1800flowersinc.com.

FLWS-COMP
FLWS-FN

View source version on businesswire.com: https://www.businesswire.com/news/home/20260819221041/en/

Investors Contact:

Andy Milevoj

[email protected]

Media:

[email protected]

Source: 1-800-FLOWERS.COM, Inc.

VivoPower International PLC (VIVO) – De-Risked Nordic AI Infrastructure Pure-Play

Posted on by [email protected]


Wednesday, August 19, 2026

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

George Proost, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Shareholder debt fully retired, materially improving credit quality. On August 3, 2026, VivoPower eliminated 100% of its $28.8m shareholder debt principal owed to AWN Holdings. $16.5 million was converted under PIPE 2 and $12.3 million was repaid in cash. The move removes the associated interest expense and materially improves credit quality ahead of the Nordic AI buildout, leaving no principal obligation to AWN.

PIPE secured to fund the AI conversion. A $50 million PIPE priced at US$7.50 per share on July 29, 2026, was led by Blue Sky Capital, alongside Nordic, EU, and GCC institutional and family-office investors. Proceeds are directed at the Mo i Rana AI data center conversion in Norway and further debt reduction.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Moderna Doubled Today on a Cancer Vaccine Breakthrough

Posted on by [email protected]

Moderna (Nasdaq: MRNA) shares more than doubled Wednesday after the company and Merck (NYSE: MRK) announced their personalized mRNA cancer vaccine met its primary and key secondary endpoints in a pivotal Phase 3 trial, the first positive late-stage result ever recorded for an individualized neoantigen cancer therapy and for any mRNA-based cancer treatment. The rally lifted biotech stocks broadly, with investors treating the result as validation for an entirely new category of oncology treatment that has been in development for more than a decade.

The trial, called INTerpath-001, enrolled 1,137 patients with completely resected stage IIB-IV melanoma, the deadliest form of skin cancer. Patients received either the vaccine, known as intismeran autogene, alongside Merck’s Keytruda, or Keytruda alone. The combination produced statistically significant and clinically meaningful improvements in recurrence-free survival, the trial’s primary endpoint, along with a secondary measure of how long patients went without their cancer spreading to distant parts of the body. No new safety signals emerged.

How the Vaccine Actually Works

What makes intismeran genuinely novel is that it is not a single, mass-produced product. Each dose is manufactured individually based on the specific mutational fingerprint of a patient’s own tumor, sequenced from surgically removed tissue, and designed to train the immune system to recognize as many as 34 distinct targets unique to that patient’s cancer. Neoantigen vaccines built on this personalized model have been discussed as a theoretical possibility in oncology for years. This is the first randomized Phase 3 trial to actually prove the concept works in a large patient population, which is precisely why the result is being described across the biotech industry as a landmark moment rather than an incremental clinical update. Notably, the trial was stopped at its first interim analysis, meaning the question of whether the vaccine ultimately extends overall survival, not just delays recurrence, remains open and could take years to fully answer. The companies have indicated they intend to pursue regulatory filings quickly, describing a timeline measured in months rather than years.

What It Means for Smaller Biotech Companies

For investors tracking small and microcap biotech, a validation event of this scale rarely stays contained to the two companies involved. Proof that personalized, sequencing-based cancer vaccines can succeed in a randomized Phase 3 trial provides real clinical and regulatory validation for an entire mechanism, and that validation tends to lift sentiment and capital allocation across every smaller company pursuing related or adjacent immuno-oncology approaches, not just the two large caps that generated today’s headline. Smaller oncology-focused biotechs, including companies like MAIA Biotechnology, both advancing their own differentiated approaches to hard-to-treat cancers, operate in exactly the kind of therapeutic environment where a breakthrough of this magnitude tends to draw renewed institutional attention to the broader category, even when their own mechanisms differ meaningfully from Moderna and Merck’s personalized vaccine platform.

This pattern is consistent with what we detailed in our recent look at the current biotech catalyst environment, where clinical breakthroughs at any point in the sector, whether at a large pharma partnership or a clinical-stage microcap, tend to reprice risk and opportunity across the entire space rather than staying isolated to a single company’s stock.

Anthropic Could Top SpaceX as the Largest IPO of 2026

Posted on by [email protected]

The race for the largest IPO of 2026 has a new challenger, and it hasn’t even filed a public prospectus yet. Prediction market data from Polymarket shows Anthropic rapidly closing the gap with SpaceX for the title of the year’s biggest public offering, driven by revenue growth that is accelerating faster than most analysts had modeled just months ago. Bloomberg reported that Anthropic’s annualized revenue for 2026 is now on track to top $65 billion, up sharply from a $47 billion pace in May, positioning the company for a potential fourth quarter market debut.

Notably, OpenAI, Anthropic’s chief rival and another company that could plausibly go public later this year, is not currently registering as a serious contender in the same prediction market data, despite its own scale and continued speculation about a near-term listing.

SpaceX Still Holds the Crown, for Now

For context on what Anthropic would actually need to beat, SpaceX priced its historic offering at $135 per share on June 11, selling 555.6 million shares and valuing the company at $1.78 trillion. The stock opened for trading the following day around $150 and climbed steadily through the session on heavy institutional and retail demand, closing its first day at $160.95, a 19.2% gain that instantly pushed SpaceX’s market capitalization to $2.1 trillion. Shares later peaked near $225 before falling to lows around $104 as investors grew concerned about upcoming lockup expirations and the scale of the company’s capital expenditure plans, a volatility pattern we detailed closely in our coverage of the debut itself. SpaceX has since recovered to roughly $146 a share, valuing the company at $1.93 trillion.

One market strategist covering the name recently argued that betting against Elon Musk has historically been a losing strategy and expects that to remain true here as well, while cautioning investors to prepare for continued sharp swings in either direction.

What the Anthropic Comparison Actually Reveals

Anthropic is currently valued at approximately $1 trillion in private markets, compared to $894 billion for OpenAI, according to Yahoo Finance private market tracking data. That $65 billion annualized revenue run rate is the more important number in this story, since prediction markets are not simply betting on company size, they are betting on whether Anthropic’s growth trajectory can support an offering large enough to eclipse SpaceX’s historic debut, an event we covered as it happened back on June 12.

For investors watching the 2026 IPO calendar, and by extension the broader capital rotation such offerings tend to trigger across public markets, this is worth tracking closely for a specific reason. When Anthropic filed confidentially for its IPO this summer at a reported valuation approaching $965 billion, we noted that the AI capital cycle had entered a genuinely new phase. A fourth quarter debut that could rival or exceed SpaceX’s own historic listing would represent the clearest confirmation yet of that thesis, and would likely reignite the same kind of capital rotation into smaller AI infrastructure and services companies that followed SpaceX’s own debut in June.

Release – DLH to Provide Mission-Critical Cyber Support for U.S. Navy

Posted on by [email protected]
logo

Research News and Market Data on DLHC

August 18, 2026

PDF Version

ATLANTA, Aug. 18, 2026 (GLOBE NEWSWIRE) — DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital transformation and cybersecurity, systems engineering and integration, and science research and development, today announced it has been awarded a multiple-award indefinite delivery/indefinite quantity (“MAC ID/IQ”) contract to provide technical services in support of cyberspace activities for the U.S. Navy. The Cyberspace Science, Research, Engineering and Technology Integration Unrestricted Multiple Award Contract is administered by Naval Information Warfare Center (“NIWC”) Pacific.

Through task orders to be competed under this contract, DLH will have the opportunity to support the architecture, engineering, functionality, interface, and interoperability of cyberspace systems, services, and capabilities at the tactical, operational, and strategic levels, including all enabling technologies. Services may include technology assessment, systems engineering, software and hardware development and prototyping, modeling and simulation, training support, and cybersecurity.

DLH is one of 29 prime awardees of the contract, which includes a base period of five years and one option period of two additional years. The contract has a total ceiling for all awardees of $400 million. Task orders are expected to be released under the contract, for which DLH expects to compete.

“DLH leverages speed, agility, world-class engineering services, and leading-edge technology, including artificial intelligence and machine learning, to deliver mission-critical cyber support,” said Billy Burnett, President of DLH’s Defense & Security business group. “This award expands the avenues available to our company to support Navy customers.”

About DLH

DLH (NASDAQ: DLHC) enhances technology, public health, and cyber security readiness missions through science, technology, cyber, and engineering solutions and services. Our experts solve some of the most complex and critical missions faced by federal customers, leveraging digital transformation, artificial intelligence, advanced analytics, cloud-based applications, telehealth systems, and more. With a world-class workforce dedicated to the idea that “Your Mission is Our Passion,” DLH brings a unique combination of government sector experience, proven methodology, and unwavering commitment to innovative solutions to improve the lives of millions. For more information, visit www.DLHcorp.com.

Contact Information:

Investor Relations
[email protected]

Media
[email protected]

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or DLH`s future financial performance. Any statements that refer to expectations, projections or other characterizations of future events or circumstances or that are not statements of historical fact (including without limitation statements to the effect that the Company or its management “believes”, “expects”, “anticipates”, “plans”, “intends” and similar expressions) should be considered forward-looking statements that involve risks and uncertainties which could cause actual events or DLH’s actual results to differ materially from those indicated by the forward-looking statements. Forward-looking statements in this release include, among others, statements regarding the anticipated use of proceeds. These statements reflect our belief and assumptions as to future events that may not prove to be accurate. Our actual results may differ materially from such forward-looking statements due to a variety of factors, including: the failure to achieve the anticipated benefits of any future acquisition (including anticipated future financial operating performance and results); the inability to retain employees and customers; contract awards in connection with re-competes for present business and/or competition for new business; our ability to manage our debt obligations; compliance with bank financial and other covenants; changes in client budgetary priorities; government contract procurement (such as bid and award protests, small business set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; significant delays or reductions in appropriations for our programs and broader changes in U.S. government funding and spending patterns; legislation that amends or changes discretionary spending levels or budget priorities; legal, regulatory, and political changes from the federal government that could result in economic uncertainty; the impact of inflation and higher interest rates; and other risks described in our SEC filings. For a discussion of such risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s periodic reports filed with the SEC, including our Annual Report on Form 10-K for the fiscal year ended September 30, 2025, as well as interim quarterly filings thereafter. The forward-looking statements contained herein are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry and business.

Such forward-looking statements are made as of the date hereof and may become outdated over time. The Company does not assume any responsibility for updating forward-looking statements.